# Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)

> **NCT03028974** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 77 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Fluzone®
- **BIOLOGICAL:** FluMist®

## Key facts

- **NCT ID:** NCT03028974
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-17
- **Primary completion:** 2017-11-20
- **Final completion:** 2017-11-20
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2018-12-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03028974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03028974, "Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03028974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*